Munder Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Munder Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4.12M	Buy	+25,685	New	+$3.95M	0.03%	318
2014 Q2	–	Sell	-105	Closed	-$15K	–	670
2014 Q1	$15K	Sell	105 -38,770	-100%	-$5.84M	﹤0.01%	649
2013 Q4	$4.92M	Buy	38,875 +36,810	+1,783%	+$3.81M	0.04%	303
2013 Q3	$189K	Sell	2,065 -215	-9%	-$17.3K	﹤0.01%	554
2013 Q2	$156K	Buy	+2,280	New	+$139K	﹤0.01%	570

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Munder Capital Management's JAZZ Position: Q3 2014 in Review

Munder Capital Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2014: 25,685 shares worth $4.12M. The stake represents 0.03% of the portfolio and ranks #318 among its holdings. This is a return to the name: Munder Capital Management previously reported a position in JAZZ as recently as Q1 2014.

Munder Capital Management first reported a position in JAZZ in Q2 2013 and has held it in 5 quarters since. The position peaked at $4.92M in Q4 2013. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

Munder Capital Management held 25,685 shares of Jazz Pharmaceuticals worth $4.12M as of Q3 2014.
Jazz Pharmaceuticals was a new Munder Capital Management position in Q3 2014.
Jazz Pharmaceuticals made up 0.03% of Munder Capital Management's portfolio in Q3 2014, its #318 holding.
Munder Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
Munder Capital Management's Jazz Pharmaceuticals position peaked at $4.92M in Q4 2013.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.